Mediterranean Diet and Gut Microbiome in Neurodegeneration: A Review

Neurodegenerative conditions such as Alzheimer’s disease and Parkinson’s disease impose a substantial burden on patients and public health resources. With no curative therapies currently available, investigators focus on lifestyle modifications like the Mediterranean diet to preserve brain health and delay disease progression. The diet features high intakes of fruits, vegetables, whole grains, legumes, nuts, and seeds, alongside extra-virgin olive oil, fish, poultry, and fermented dairy products in moderation.

This dietary structure supplies high levels of bioactive compounds, including omega-3 fatty acids, vitamins, and minerals. These elements mitigate oxidative stress, regulate inflammation, improve vascular function, and reduce neuronal injury. Adherence to the dietary pattern correlates with slower cognitive decline and a reduced risk of dementia, particularly Alzheimer’s disease, though the precise role of the gut microbiome in these mechanisms remains unclear.

The gut microbiome consists of trillions of microbes vital for intestinal, immune, and neurological homeostasis. These organisms communicate with the central nervous system through the gut-brain axis by signaling via microbial metabolites, immune mediators, hormones, and vagal nerve impulses. Dysbiosis, characterized by altered microbial composition, reduced diversity, and impaired function, can compromise the intestinal epithelial barrier.

Compromised barrier function may lead to increased intestinal permeability, allowing the translocation of microbes and pro-inflammatory components like lipopolysaccharides into systemic circulation. This process promotes chronic low-grade inflammation, which can subsequently increase blood-brain barrier permeability, oxidative stress, and microglial activation within the central nervous system.

Dietary Components and Microbial Metabolites

The Mediterranean diet promotes microbial diversity and metabolic resilience by providing diverse substrates for colonic microbes. Fiber and nondigestible carbohydrates from whole grains, legumes, fruits, vegetables, nuts, and seeds undergo fermentation to generate short-chain fatty acids such as butyrate. These metabolites promote epithelial function, mucus production, and intestinal barrier integrity.

Short-chain fatty acids reduce local and systemic inflammation, oxidative stress, and metabolic dysfunction through immunomodulatory effects, though their impact depends on the specific metabolite and host environment. Additional metabolites associated with the diet include secondary bile acids with metabolic and immunoregulatory properties, alongside indoles that regulate mucosal immunity and support epithelial integrity.

Extra-virgin olive oil provides monounsaturated fatty acids, predominantly oleic acid, and phenolics that exert prebiotic effects by encouraging the growth of short-chain fatty acid-producing bacteria. Fatty fish deliver long-chain omega-3 polyunsaturated fatty acids like eicosapentaenoic acid and docosahexaenoic acid, while walnuts supply plant-derived alpha-linolenic acid. Fermented dairy products such as yogurt and kefir contribute live microbes and fermentation compounds that influence intestinal immune signaling, although probiotic benefits remain product- and strain-specific.

Evidence Gaps in Microbiome-Mediated Neuroprotection

Despite strong theoretical links between dietary intake, microbiome shifts, and neurological health, the review highlights that direct human evidence demonstrating these microbiome changes actually mediate neuroprotection is scarce. While omega-3 fatty acids reduce oxidative stress and inflammatory signaling, their effects vary according to individual diet, microbiome composition, dose, and metabolic status.

Researchers say that establishing definitive causal pathways requires targeted clinical investigations to track how specific microbial metabolites cross the blood-brain barrier in human populations.